Package Description

Antibiotic resistance is a major public health threat, with “superbug” infections occurring in an estimated 2.8 million people in the US each year. Antibiotic misuse and overuse are the primary reasons for the development of antibiotic resistance and adverse reactions—most notably life-threatening Clostridioides difficile infection (C. Diff). The risk/benefit of prescribing antibiotics must always be considered before prescribing any antibiotic.

The Centers for Disease Control and Prevention (CDC) recommends that all outpatient healthcare providers take steps to measure and improve how antibiotics are prescribed. While stewardship principles are well-defined for outpatient settings, the dental setting, with the majority practicing in private practice, provides unique challenges. Barriers to implementing and evaluating successful stewardship programs come when dental teams operate individually. 

This event took place in February 2024, and addressed antibiotic stewardship in the oral healthcare setting. In this program, guidelines for the use of antibiotics for prophylaxis and treatment of oral infections were reviewed, the use of tools for screening for penicillin allergies, testing, and delabeling, and challenges to responsible prescribing were discussed. Participants were be provided with numerous clinical tips, tools, and resources to develop and implement antibiotic stewardship programs in their own practice. 

Learning Objectives:

• Review the regulatory and national landscape for antimicrobial stewardship for dentistry.
• Identify national guidelines and best practices for antimicrobial stewardship programs.
• Identify national guidelines and best practices for assessing and testing for true penicillin allergies.
• Discuss barriers, challenges, and opportunities for implementing and evaluating antimicrobial stewardship programs in the dental setting.
• Identify tools and resources to support developing and implementing a successful antimicrobial stewardship program in oral healthcare.

Price

• Members and Non-Members: Free 

Benefits

• Up to 6.50 hours of content worth ADA CERP CE credits through February 28, 2027.
• Each recording comes with access to the PowerPoint and any other materials the speaker may have provided.
• Available any time from the comfort of your home, office, or on the go.
• All of the invaluable information from the course, without any of the travel expenses!

CONTINUING EDUCATION

OSAP is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Please email the OSAP office at office@osap.org or call +1 (410) 571-0003 if you wish to be in contact with the course author/creator(s) with any questions or for clarification of course concepts or for technical assistance in completing the online test.

All participants assume individual responsibility for providing evidence of contact hours of continuing education to the appropriate authorities and for the maintenance of their individual records.

Learn more about OSAP’s CE Program & Provider Recognition.

CE CREDITS: 6.50
EDUCATIONAL METHOD: Self-instructional (self-study)
LOCATION: Online
PUBLICATION DATE: February 2024
EXPIRATION DATE: February 28, 2027

DISCLOSURE:

All participating faculty are expected to disclose to the audience any significant financial interest or other relationship with:

1. the manufacturer of any commercial products and/or provider of commercial services discussed in an educational presentation and
2. any commercial supporters of the activity.

CE DISCLAIMER:

Authors of CE activities are required to present a balanced view of therapeutic options, use generic names of products whenever possible, use images that have not been falsified or misrepresent the outcome of treatment, and refrain from marketing or promoting any products or commercial services. Authors are required to include peer-reviewed content supported by generally accepted scientific principles or methods that can be substantiated or supported with peer-reviewed scientific literature that is relevant and current. Authors must support clinical recommendations with references from the scientific literature, with a sound scientific basis, whenever possible. Authors of CE activities are required to disclose to participants any financial, commercial, or promotional interest in a product or company that may influence their participation.